Search by Drug Name or NDC
NDC 00078-0911-12 Xiidra 50 mg/mL Details
Xiidra 50 mg/mL
Xiidra is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is LIFITEGRAST.
MedlinePlus Drug Summary
Ophthalmic lifitegrast is used to treat the signs and symptoms of dry eye disease. Lifitegrast is in a class of medications called lymphocyte function-associated antigen-1 (LFA-1) antagonist. Lifitegrast works by reducing the swelling in the eye tissues.
Related Packages: 00078-0911-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lifitegrast Ophthalmic
Product Information
| NDC | 00078-0911 |
|---|---|
| Product ID | 0078-0911_d4d1ca2a-8c29-477e-bdd1-7e536daa28cf |
| Associated GPIs | 86734050002020 |
| GCN Sequence Number | 076360 |
| GCN Sequence Number Description | lifitegrast DROPERETTE 5 % OPHTHALMIC |
| HIC3 | Q2C |
| HIC3 Description | OPHTHALMIC ANTI-INFLAMMATORY IMMUNOMODULATOR-TYPE |
| GCN | 41847 |
| HICL Sequence Number | 043610 |
| HICL Sequence Number Description | LIFITEGRAST |
| Brand/Generic | Brand |
| Proprietary Name | Xiidra |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lifitegrast |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIFITEGRAST |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA208073 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0911-12 (00078091112)
| NDC Package Code | 0078-0911-12 |
|---|---|
| Billing NDC | 00078091112 |
| Package | 12 POUCH in 1 CARTON (0078-0911-12) / 5 AMPULE in 1 POUCH (0078-0911-05) / .2 mL in 1 AMPULE |
| Marketing Start Date | 2020-06-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 11.2357 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | XIIDRA 5% EYE DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis